Molina Healthcare, Inc $MOH Holdings Lifted by Savant Capital LLC

Savant Capital LLC grew its holdings in shares of Molina Healthcare, Inc (NYSE:MOH) by 153.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,140 shares of the company’s stock after buying an additional 17,634 shares during the period. Savant Capital LLC owned 0.05% of Molina Healthcare worth $5,576,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. First Horizon Advisors Inc. boosted its position in Molina Healthcare by 2,140.0% during the 2nd quarter. First Horizon Advisors Inc. now owns 112 shares of the company’s stock worth $33,000 after acquiring an additional 107 shares during the period. Bogart Wealth LLC acquired a new position in shares of Molina Healthcare during the third quarter valued at $39,000. CYBER HORNET ETFs LLC bought a new stake in shares of Molina Healthcare during the second quarter valued at about $45,000. MUFG Securities EMEA plc acquired a new stake in Molina Healthcare in the second quarter worth about $48,000. Finally, SJS Investment Consulting Inc. grew its position in Molina Healthcare by 6,225.0% in the 3rd quarter. SJS Investment Consulting Inc. now owns 253 shares of the company’s stock valued at $48,000 after buying an additional 249 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Molina Healthcare Stock Down 0.8%

MOH opened at $176.69 on Friday. The firm has a market cap of $9.58 billion, a P/E ratio of 10.94 and a beta of 0.49. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.68 and a current ratio of 1.68. The business has a 50 day moving average price of $173.55 and a 200 day moving average price of $171.21. Molina Healthcare, Inc has a twelve month low of $133.40 and a twelve month high of $359.97.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Thursday, February 5th. The company reported ($2.75) EPS for the quarter, missing the consensus estimate of $0.43 by ($3.18). The company had revenue of $11.38 billion for the quarter, compared to analyst estimates of $10.90 billion. Molina Healthcare had a net margin of 1.98% and a return on equity of 22.95%. The company’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same quarter last year, the business earned $5.05 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Research analysts forecast that Molina Healthcare, Inc will post 24.4 EPS for the current year.

Molina Healthcare News Roundup

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Revenue beat and top‑line growth — Molina reported revenue of $11.38B for Q4, above consensus and up ~8.3% year‑over‑year, showing continued member/revenue scale. Press Release
• Neutral Sentiment: Analyses and metric comparisons — Several pieces (Zacks, SFGate) walk through how key metrics compared to Street estimates; useful for investors wanting detail on margins, membership and cost drivers. Zacks Analysis
• Negative Sentiment: Huge EPS miss — Q4 reported EPS of ($2.75) vs. consensus ~$0.43 and vs prior‑year $5.05, a shocking swing that triggered the initial selloff. Zacks Loss Report
• Negative Sentiment: Material downward guidance — Molina updated FY‑2026 EPS guidance to roughly $5 (vs. Street ~$12.95), signaling that Obamacare/individual market cost pressures will weigh all year. This guidance reduction is the primary driver of the larger share‑price decline. Reuters: Forecast Below Estimates
• Negative Sentiment: Analyst reaction — Bank of America reiterated a Sell and cut its price target to $145, reflecting lowered earnings expectations and policy/market uncertainty. Analyst downgrades amplify selling pressure. TipRanks / BofA
• Negative Sentiment: Market reaction and headlines — The stock plunged ~30%+ in after‑hours trading on the surprise loss, guidance cut and negative headlines (coverage notes and retail commentary). That immediate liquidity hit can extend intraday weakness. Benzinga

Insider Buying and Selling at Molina Healthcare

In related news, Director Richard M. Schapiro sold 357 shares of the stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $143.02, for a total transaction of $51,058.14. Following the completion of the sale, the director owned 11,352 shares in the company, valued at $1,623,563.04. This represents a 3.05% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.10% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft set a $165.00 price objective on shares of Molina Healthcare in a report on Friday, October 24th. TD Cowen cut Molina Healthcare from a “buy” rating to a “hold” rating and set a $203.00 price target on the stock. in a research report on Thursday, October 16th. Morgan Stanley set a $158.00 price objective on Molina Healthcare in a report on Friday, October 24th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $224.00 target price on shares of Molina Healthcare in a report on Tuesday, January 6th. Finally, Mizuho set a $220.00 price target on shares of Molina Healthcare in a report on Friday, January 9th. Three equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $182.64.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.